Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Cosan Sa Spon ADR WI (CSAN)

Cosan Sa Spon ADR WI (CSAN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Author
10 Best Sugar Stocks to Buy Now MarketBeat - Mon Jul 31, 2023

No individual sugar-producing companies trade on major U.S. stock exchanges, so should you invest? Learn more about the best sugar stocks to buy on MarketBeat.

CZZ : 20.29 (+2.01%)
ARGO : 29.99 (-0.03%)
VEGI : 37.90 (+6.97%)
AGRO.CN : 0.040 (unch)
AGRO : 9.43 (+0.96%)
ADM : 51.00 (+0.95%)
BG : 77.76 (+1.13%)
CSAN : 5.25 (-3.49%)
DE : 423.70 (unch)
DBA : 26.59 (+1.22%)
MSCI : 600.01 (+0.06%)
PEP : 152.60 (+0.36%)
Cosan S.A. (CSAN) Q2 2022 Earnings Call Transcript Motley Fool - Mon Aug 15, 2022

CSAN earnings call for the period ending June 30, 2022.

CSAN : 5.25 (-3.49%)
Cosan S.A. (CSAN) Q1 2022 Earnings Call Transcript Motley Fool - Mon May 16, 2022

CSAN earnings call for the period ending March 31, 2022.

CSAN : 5.25 (-3.49%)
Cosan S.A. (CSAN) Q4 2021 Earnings Call Transcript Motley Fool - Tue Feb 22, 2022

CSAN earnings call for the period ending December 31, 2021.

CSAN : 5.25 (-3.49%)

Barchart Exclusives

Tarsus Pharmaceutical - Eye Care Therapeutics Barchart - 1 hour ago
Summary Tarsus Pharmaceuticals (TARS) has shown strong technical indicators, including a 48.35% gain since the Trend Seeker buy signal on 9/4 and 173.43% gain in the last year. The company focuses on novel eye care therapeutics, with its lead product XDEMVY targeting blepharitis caused by Demodex mites and other promising... Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot